158 related articles for article (PubMed ID: 28962066)
21. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease.
Smeding HM; Speelman JD; Huizenga HM; Schuurman PR; Schmand B
J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):754-60. PubMed ID: 19465417
[TBL] [Abstract][Full Text] [Related]
22. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
[TBL] [Abstract][Full Text] [Related]
24. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
25. Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.
Hariz GM; Limousin P; Zrinzo L; Tripoliti E; Aviles-Olmos I; Jahanshahi M; Hamberg K; Foltynie T
Acta Neurol Scand; 2013 Oct; 128(4):281-5. PubMed ID: 23550919
[TBL] [Abstract][Full Text] [Related]
26. [Effects of bilateral deep brain stimulation in the subthalamic nucleus using two methods of target structure verification].
Goubareva NN; Fedorova NV; Bril' EV; Tomskiy AA; Gamaleya AA; Poddubskaya AA; Shabalov VA; Omarova SM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):24-30. PubMed ID: 29265083
[TBL] [Abstract][Full Text] [Related]
27. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.
Kleiner-Fisman G; Herzog J; Fisman DN; Tamma F; Lyons KE; Pahwa R; Lang AE; Deuschl G
Mov Disord; 2006 Jun; 21 Suppl 14():S290-304. PubMed ID: 16892449
[TBL] [Abstract][Full Text] [Related]
28. Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial.
Marques A; Chassin O; Morand D; Pereira B; Debilly B; Derost P; Ulla M; Lemaire JJ; Durif F
Neurology; 2013 Aug; 81(7):633-40. PubMed ID: 23864314
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
30. Fusion image-based programming after subthalamic nucleus deep brain stimulation.
Paek SH; Kim HJ; Yoon JY; Heo JH; Kim C; Kim MR; Lim YH; Kim KR; Kim JW; Han JH; Kim DG; Jeon BS
World Neurosurg; 2011; 75(3-4):517-24. PubMed ID: 21600506
[TBL] [Abstract][Full Text] [Related]
31. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.
Rodriguez-Oroz MC; Zamarbide I; Guridi J; Palmero MR; Obeso JA
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1382-5. PubMed ID: 15377681
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
[TBL] [Abstract][Full Text] [Related]
35. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
[TBL] [Abstract][Full Text] [Related]
36. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Vingerhoets FJ; Villemure JG; Temperli P; Pollo C; Pralong E; Ghika J
Neurology; 2002 Feb; 58(3):396-401. PubMed ID: 11839838
[TBL] [Abstract][Full Text] [Related]
37. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
38. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
Derost PP; Ouchchane L; Morand D; Ulla M; Llorca PM; Barget M; Debilly B; Lemaire JJ; Durif F
Neurology; 2007 Apr; 68(17):1345-55. PubMed ID: 17452578
[TBL] [Abstract][Full Text] [Related]
39. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.
Pinter MM; Alesch F; Murg M; Seiwald M; Helscher RJ; Binder H
J Neural Transm (Vienna); 1999; 106(7-8):693-709. PubMed ID: 10907728
[TBL] [Abstract][Full Text] [Related]
40. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
